Can Fite Biopharma Ltd (CANF) — Cash Flow-to-Debt Ratio
Can Fite Biopharma Ltd (CANF) has a Cash Flow-to-Debt Ratio of -0.67x as of June 2025, meaning its operating cash flow of ILA-2.38 Million could theoretically repay -1% of its total liabilities (ILA3.54 Million) in one year. See Can Fite Biopharma Ltd (CANF) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Can Fite Biopharma Ltd Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Can Fite Biopharma Ltd across 16 annual periods. Also explore net asset growth rate of Can Fite Biopharma Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Can Fite Biopharma Ltd (2010–2025)
Year-by-year debt coverage analysis for Can Fite Biopharma Ltd. For market capitalisation and broader financial context, see market cap of Can Fite Biopharma Ltd.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.47x | ILA-9.69 Million | ILA3.92 Million | ▼ -19.1% |
| 2024 | -2.07x | ILA-7.64 Million | ILA3.68 Million | ▲ +8.0% |
| 2023 | -2.25x | ILA-8.44 Million | ILA3.75 Million | ▼ -0.4% |
| 2022 | -2.25x | ILA-10.80 Million | ILA4.81 Million | ▼ -33.7% |
| 2021 | -1.68x | ILA-9.86 Million | ILA5.87 Million | ▲ +52.0% |
| 2020 | -3.50x | ILA-12.06 Million | ILA3.45 Million | ▼ -85.0% |
| 2019 | -1.89x | ILA-10.83 Million | ILA5.73 Million | ▼ -124.6% |
| 2018 | -0.84x | ILA-4.16 Million | ILA4.94 Million | ▲ +57.8% |
| 2017 | -1.99x | ILA-9.52 Million | ILA4.78 Million | ▼ -40.5% |
| 2016 | -1.42x | ILA-8.93 Million | ILA6.29 Million | ▼ -118.2% |
| 2015 | -0.65x | ILA-4.65 Million | ILA7.16 Million | ▲ +70.5% |
| 2014 | -2.20x | ILA-7.33 Million | ILA3.33 Million | ▲ +44.5% |
| 2013 | -3.97x | ILA-8.63 Million | ILA2.18 Million | ▼ -113.7% |
| 2012 | -1.86x | ILA-4.35 Million | ILA2.34 Million | ▲ +45.6% |
| 2011 | -3.41x | ILA-5.50 Million | ILA1.61 Million | ▼ -410.8% |
| 2010 | -0.67x | ILA-3.65 Million | ILA5.47 Million | — |